Process View
50 genes annotated in human
DOID:0050700
A heart disease and a myopathy that is characterized by deterioration of the function of the heart muscle.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "cardiomyopathy"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| TRIM63 | tripartite motif containing 63 | 1.000 | ||
| NEB | nebulin | 1.000 | ||
| TNNI1 | troponin I type 1 (skeletal, slow) | 1.000 | Human | |
| TNNC1 | troponin C type 1 (slow) | 1.000 | ||
| TTN | titin | 1.000 | ||
| MYOZ1 | myozenin 1 | 1.000 | Human | |
| HSPB8 | heat shock 22kDa protein 8 | 0.999 | Human | |
| FLNC | filamin C, gamma | 0.997 | ||
| CTNNA1 | catenin (cadherin-associated protein), alpha 1, 102kDa | 0.995 | Human | |
| HSPB1 | heat shock 27kDa protein 1 | 0.995 | ||
| ACTN2 | actinin, alpha 2 | 0.994 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.993 | ||
| TCAP | titin-cap (telethonin) | 0.993 | ||
| DSG2 | desmoglein 2 | 0.992 | ||
| CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.990 | Human | |
| DSC2 | desmocollin 2 | 0.985 | ||
| TNNT2 | troponin T type 2 (cardiac) | 0.981 | ||
| DSP | desmoplakin | 0.976 | ||
| CDH1 | cadherin 1, type 1, E-cadherin (epithelial) | 0.973 | Human | |
| TPM2 | tropomyosin 2 (beta) | 0.971 | Human | |
| HSPB2 | heat shock 27kDa protein 2 | 0.967 | Human | |
| FLNB | filamin B, beta | 0.960 | ||
| DTNA | dystrobrevin, alpha | 0.924 | ||
| MYH7 | myosin, heavy chain 7, cardiac muscle, beta | 0.923 | ||
| ACTA1 | actin, alpha 1, skeletal muscle | 0.922 | Human | |
| MYH6 | myosin, heavy chain 6, cardiac muscle, alpha | 0.919 | ||
| TNNT1 | troponin T type 1 (skeletal, slow) | 0.914 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.902 | ||
| PKP2 | plakophilin 2 | 0.888 | ||
| CSRP3 | cysteine and glycine-rich protein 3 (cardiac LIM protein) | 0.840 | ||
| PKP4 | plakophilin 4 | 0.838 | Human | |
| PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.830 | ||
| PTN | pleiotrophin | 0.803 | ||
| MYL2 | myosin, light chain 2, regulatory, cardiac, slow | 0.801 | ||
| JUP | junction plakoglobin | 0.758 | ||
| CRYAB | crystallin, alpha B | 0.754 | ||
| MYH9 | myosin, heavy chain 9, non-muscle | 0.751 | ||
| MYL3 | myosin, light chain 3, alkali; ventricular, skeletal, slow | 0.708 | ||
| MARK3 | MAP/microtubule affinity-regulating kinase 3 | 0.697 | ||
| SGCG | sarcoglycan, gamma (35kDa dystrophin-associated glycoprotein) | 0.690 | Human | |
| CAV3 | caveolin 3 | 0.657 | ||
| PSEN1 | presenilin 1 | 0.636 | ||
| MYOZ2 | myozenin 2 | 0.630 | ||
| CRYBB2 | crystallin, beta B2 | 0.594 | ||
| ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 0.591 | ||
| BCL2L1 | BCL2-like 1 | 0.564 | ||
| ANKRD2 | ankyrin repeat domain 2 (stretch responsive muscle) | 0.558 | ||
| TNNI2 | troponin I type 2 (skeletal, fast) | 0.539 | Human | |
| FLNA | filamin A, alpha | 0.532 | ||
| SNTG2 | syntrophin, gamma 2 | 0.523 | ||
| HSPB7 | heat shock 27kDa protein family, member 7 (cardiovascular) | 0.489 | ||
| CASQ2 | calsequestrin 2 (cardiac muscle) | 0.488 | ||
| TCF7L2 | transcription factor 7-like 2 (T-cell specific, HMG-box) | 0.472 | ||
| SDHB | succinate dehydrogenase complex, subunit B, iron sulfur (Ip) | 0.465 | ||
| TNNT3 | troponin T type 3 (skeletal, fast) | 0.450 | Human | |
| SMPX | small muscle protein, X-linked | 0.450 | ||
| ATP2A1 | ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 | 0.437 | ||
| CRYAA | crystallin, alpha A | 0.424 | Human | |
| TRIP6 | thyroid hormone receptor interactor 6 | 0.423 | ||
| XIRP1 | xin actin-binding repeat containing 1 | 0.391 | ||
| NCSTN | nicastrin | 0.390 | ||
| MYL4 | myosin, light chain 4, alkali; atrial, embryonic | 0.376 | Human | |
| TNNI3K | TNNI3 interacting kinase | 0.371 | ||
| LDB3 | LIM domain binding 3 | 0.359 | ||
| ACTC1 | actin, alpha, cardiac muscle 1 | 0.351 | ||
| OBSCN | obscurin, cytoskeletal calmodulin and titin-interacting RhoGEF | 0.347 | ||
| MYL1 | myosin, light chain 1, alkali; skeletal, fast | 0.327 | Human | |
| ACTA2 | actin, alpha 2, smooth muscle, aorta | 0.326 | Human | |
| SVIL | supervillin | 0.325 | ||
| TNNI3 | troponin I type 3 (cardiac) | 0.324 | ||
| CKM | creatine kinase, muscle | 0.286 | ||
| CTNNBIP1 | catenin, beta interacting protein 1 | 0.285 | ||
| FHL2 | four and a half LIM domains 2 | 0.279 | ||
| ANK1 | ankyrin 1, erythrocytic | 0.275 | ||
| MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.261 | ||
| SYNM | synemin, intermediate filament protein | 0.260 | Human | |
| MRPL41 | mitochondrial ribosomal protein L41 | 0.259 | ||
| APH1A | anterior pharynx defective 1 homolog A (C. elegans) | 0.256 | ||
| DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.250 | ||
| KCNA5 | potassium voltage-gated channel, shaker-related subfamily, member 5 | 0.248 | ||
| CNN1 | calponin 1, basic, smooth muscle | 0.245 | ||
| HSPB3 | heat shock 27kDa protein 3 | 0.244 | Human | |
| MYBPC1 | myosin binding protein C, slow type | 0.243 | ||
| BAD | BCL2-associated agonist of cell death | 0.239 | ||
| UTRN | utrophin | 0.236 | Human | |
| ANKRD1 | ankyrin repeat domain 1 (cardiac muscle) | 0.234 | ||
| PRKAB2 | protein kinase, AMP-activated, beta 2 non-catalytic subunit | 0.234 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.215 | ||
| CRYGC | crystallin, gamma C | 0.212 | ||
| PRKAA1 | protein kinase, AMP-activated, alpha 1 catalytic subunit | 0.205 | ||
| AKAP6 | A kinase (PRKA) anchor protein 6 | 0.204 | ||
| ALB | albumin | 0.202 | ||
| KRT18 | keratin 18 | 0.193 | ||
| HSPA1B | heat shock 70kDa protein 1B | 0.189 | ||
| CASQ1 | calsequestrin 1 (fast-twitch, skeletal muscle) | 0.179 | ||
| MYH1 | myosin, heavy chain 1, skeletal muscle, adult | 0.177 | Human | |
| SQSTM1 | sequestosome 1 | 0.176 | ||
| WDYHV1 | WDYHV motif containing 1 | 0.170 | ||
| BAG1 | BCL2-associated athanogene | 0.169 | ||
| ITGB4 | integrin, beta 4 | 0.168 | ||
| ACTN3 | actinin, alpha 3 | 0.165 | ||
| MYOM1 | myomesin 1, 185kDa | 0.164 | ||
| MYOD1 | myogenic differentiation 1 | 0.160 | ||
| SGCA | sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein) | 0.156 | ||
| MYPN | myopalladin | 0.151 | ||
| MYOT | myotilin | 0.151 | Human | |
| USP6 | ubiquitin specific peptidase 6 (Tre-2 oncogene) | 0.150 | ||
| ACTN1 | actinin, alpha 1 | 0.142 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.138 | ||
| CALD1 | caldesmon 1 | 0.137 | ||
| MYBPC2 | myosin binding protein C, fast type | 0.136 | ||
| SLN | sarcolipin | 0.130 | ||
| COX6A2 | cytochrome c oxidase subunit VIa polypeptide 2 | 0.129 | ||
| DTNB | dystrobrevin, beta | 0.121 | ||
| RPL3L | ribosomal protein L3-like | 0.119 | ||
| DNAJB1 | DnaJ (Hsp40) homolog, subfamily B, member 1 | 0.117 | ||
| CACNA1S | calcium channel, voltage-dependent, L type, alpha 1S subunit | 0.113 | ||
| SRPK3 | SRSF protein kinase 3 | 0.107 | ||
| CAPN3 | calpain 3, (p94) | 0.103 | ||
| TUBB6 | tubulin, beta 6 | 0.101 | ||
| SYNPO2 | synaptopodin 2 | 0.100 | ||
| JPH2 | junctophilin 2 | 0.099 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.098 | ||
| MYH2 | myosin, heavy chain 2, skeletal muscle, adult | 0.094 | Human | |
| PDLIM3 | PDZ and LIM domain 3 | 0.094 | Human | |
| LMCD1 | LIM and cysteine-rich domains 1 | 0.088 | ||
| MYLPF | myosin light chain, phosphorylatable, fast skeletal muscle | 0.087 | Human | |
| KBTBD10 | kelch repeat and BTB (POZ) domain containing 10 | 0.082 | ||
| HSPB6 | heat shock protein, alpha-crystallin-related, B6 | 0.081 | Human | |
| PYGM | phosphorylase, glycogen, muscle | 0.080 | ||
| CIB1 | calcium and integrin binding 1 (calmyrin) | 0.080 | ||
| AHNAK | AHNAK nucleoprotein | 0.079 | ||
| PEBP4 | phosphatidylethanolamine-binding protein 4 | 0.079 | ||
| PTPN3 | protein tyrosine phosphatase, non-receptor type 3 | 0.077 | ||
| SUCLG1 | succinate-CoA ligase, alpha subunit | 0.077 | ||
| SNTB1 | syntrophin, beta 1 (dystrophin-associated protein A1, 59kDa, basic component 1) | 0.077 | ||
| OBSL1 | obscurin-like 1 | 0.077 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.075 | ||
| TRIM54 | tripartite motif containing 54 | 0.072 | ||
| TPM1 | tropomyosin 1 (alpha) | 0.070 | ||
| MYBPC3 | myosin binding protein C, cardiac | 0.067 | ||
| APOBEC2 | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2 | 0.067 | ||
| MYL9 | myosin, light chain 9, regulatory | 0.067 | Human | |
| PTRF | polymerase I and transcript release factor | 0.065 | ||
| MYF6 | myogenic factor 6 (herculin) | 0.064 | ||
| CALM1 | calmodulin 1 (phosphorylase kinase, delta) | 0.064 | ||
| ZHX1 | zinc fingers and homeoboxes 1 | 0.063 | ||
| TRIM55 | tripartite motif containing 55 | 0.062 | ||
| DES | desmin | 0.060 | ||
| DNAJB2 | DnaJ (Hsp40) homolog, subfamily B, member 2 | 0.060 | ||
| HSPA1A | heat shock 70kDa protein 1A | 0.059 | ||
| MB | myoglobin | 0.058 | ||
| MYLK2 | myosin light chain kinase 2 | 0.056 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.056 | ||
| CKMT2 | creatine kinase, mitochondrial 2 (sarcomeric) | 0.055 | ||
| SORBS1 | sorbin and SH3 domain containing 1 | 0.054 | ||
| PRKCI | protein kinase C, iota | 0.052 | ||
| XIRP2 | xin actin-binding repeat containing 2 | 0.052 | ||
| GFM1 | G elongation factor, mitochondrial 1 | 0.051 | ||
| HIST2H3C | histone cluster 2, H3c | 0.051 | ||
| NRAP | nebulin-related anchoring protein | 0.051 | Human | |
| SYNPO2L | synaptopodin 2-like | 0.050 | ||
| TAGLN | transgelin | 0.050 | ||
| APP | amyloid beta (A4) precursor protein | 0.048 | ||
| HOXA9 | homeobox A9 | 0.047 | ||
| MYBPH | myosin binding protein H | 0.047 | ||
| PLN | phospholamban | 0.047 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.046 | ||
| EZR | ezrin | 0.046 | ||
| FN1 | fibronectin 1 | 0.046 | ||
| BIK | BCL2-interacting killer (apoptosis-inducing) | 0.046 | ||
| ALPK3 | alpha-kinase 3 | 0.045 | ||
| ANXA3 | annexin A3 | 0.045 | ||
| MAPKAPK2 | mitogen-activated protein kinase-activated protein kinase 2 | 0.045 | ||
| FABP3 | fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | 0.044 | ||
| FERMT2 | fermitin family member 2 | 0.043 | ||
| MYH8 | myosin, heavy chain 8, skeletal muscle, perinatal | 0.043 | Human | |
| TNNC2 | troponin C type 2 (fast) | 0.043 | Human | |
| DYSF | dysferlin, limb girdle muscular dystrophy 2B (autosomal recessive) | 0.042 | ||
| TSC2 | tuberous sclerosis 2 | 0.041 | ||
| MYOG | myogenin (myogenic factor 4) | 0.041 | ||
| ZKSCAN1 | zinc finger with KRAB and SCAN domains 1 | 0.041 | ||
| DCAF6 | DDB1 and CUL4 associated factor 6 | 0.041 | ||
| PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.041 | Human | |
| CRYBA1 | crystallin, beta A1 | 0.041 | ||
| FHL3 | four and a half LIM domains 3 | 0.040 | ||
| HRC | histidine rich calcium binding protein | 0.039 | ||
| SRI | sorcin | 0.039 | ||
| ILK | integrin-linked kinase | 0.039 | ||
| PRRX1 | paired related homeobox 1 | 0.039 | ||
| FBXO40 | F-box protein 40 | 0.038 | ||
| TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.038 | ||
| NDUFS2 | NADH dehydrogenase (ubiquinone) Fe-S protein 2, 49kDa (NADH-coenzyme Q reductase) | 0.038 | ||
| HSF1 | heat shock transcription factor 1 | 0.037 | ||
| SMTNL1 | smoothelin-like 1 | 0.037 | ||
| FBP2 | fructose-1,6-bisphosphatase 2 | 0.037 | ||
| PXN | paxillin | 0.036 | ||
| ITGB1BP2 | integrin beta 1 binding protein (melusin) 2 | 0.036 | ||
| FDFT1 | farnesyl-diphosphate farnesyltransferase 1 | 0.035 | ||
| PERP | PERP, TP53 apoptosis effector | 0.035 | ||
| PGAM2 | phosphoglycerate mutase 2 (muscle) | 0.035 | ||
| MYH4 | myosin, heavy chain 4, skeletal muscle | 0.034 | Human | |
| NCAM1 | neural cell adhesion molecule 1 | 0.033 | ||
| PLEC | plectin | 0.033 | ||
| FGF7 | fibroblast growth factor 7 | 0.033 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.033 | ||
| MYH11 | myosin, heavy chain 11, smooth muscle | 0.033 | ||
| ABCC9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | 0.033 | ||
| RAPSN | receptor-associated protein of the synapse | 0.033 | ||
| LMOD2 | leiomodin 2 (cardiac) | 0.032 | ||
| GPD1 | glycerol-3-phosphate dehydrogenase 1 (soluble) | 0.032 | ||
| TPM4 | tropomyosin 4 | 0.032 | Human | |
| PKP3 | plakophilin 3 | 0.032 | Human | |
| PAFAH1B3 | platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 (29kDa) | 0.031 | ||
| PRKAG1 | protein kinase, AMP-activated, gamma 1 non-catalytic subunit | 0.031 | Human | |
| TRIM32 | tripartite motif containing 32 | 0.031 | ||
| ARL15 | ADP-ribosylation factor-like 15 | 0.031 | ||
| PRKAA2 | protein kinase, AMP-activated, alpha 2 catalytic subunit | 0.031 | ||
| FBLIM1 | filamin binding LIM protein 1 | 0.030 | ||
| ANXA2 | annexin A2 | 0.030 | ||
| DISC1 | disrupted in schizophrenia 1 | 0.030 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.030 | ||
| MYF5 | myogenic factor 5 | 0.030 | ||
| FIGF | c-fos induced growth factor (vascular endothelial growth factor D) | 0.030 | ||
| RYR1 | ryanodine receptor 1 (skeletal) | 0.030 | Human | |
| MYOZ3 | myozenin 3 | 0.030 | Human | |
| TGFBR3 | transforming growth factor, beta receptor III | 0.030 | ||
| ZYX | zyxin | 0.030 | ||
| PKD2L1 | polycystic kidney disease 2-like 1 | 0.029 | ||
| ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.028 | ||
| ANGPTL2 | angiopoietin-like 2 | 0.028 | ||
| GMEB1 | glucocorticoid modulatory element binding protein 1 | 0.028 | ||
| SCN4A | sodium channel, voltage-gated, type IV, alpha subunit | 0.028 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.028 | ||
| NDUFV1 | NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa | 0.028 | ||
| DAAM2 | dishevelled associated activator of morphogenesis 2 | 0.028 | ||
| CACNB4 | calcium channel, voltage-dependent, beta 4 subunit | 0.028 | ||
| SDC4 | syndecan 4 | 0.028 | ||
| MEF2C | myocyte enhancer factor 2C | 0.028 | ||
| CHRNG | cholinergic receptor, nicotinic, gamma | 0.027 | ||
| SLIT3 | slit homolog 3 (Drosophila) | 0.027 | ||
| ATXN3 | ataxin 3 | 0.027 | ||
| ENO3 | enolase 3 (beta, muscle) | 0.027 | ||
| NRP1 | neuropilin 1 | 0.027 | ||
| SAMM50 | sorting and assembly machinery component 50 homolog (S. cerevisiae) | 0.027 | ||
| CLU | clusterin | 0.027 | ||
| FHL1 | four and a half LIM domains 1 | 0.027 | ||
| SFN | stratifin | 0.026 | ||
| BRAF | v-raf murine sarcoma viral oncogene homolog B1 | 0.026 | Human | |
| AMPD1 | adenosine monophosphate deaminase 1 | 0.026 | ||
| CMA1 | chymase 1, mast cell | 0.026 | ||
| TRAF6 | TNF receptor-associated factor 6 | 0.026 | ||
| MYH3 | myosin, heavy chain 3, skeletal muscle, embryonic | 0.025 | Human | |
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.025 | ||
| PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit | 0.025 | ||
| UBR1 | ubiquitin protein ligase E3 component n-recognin 1 | 0.025 | ||
| S100A1 | S100 calcium binding protein A1 | 0.025 | ||
| MYOM2 | myomesin (M-protein) 2, 165kDa | 0.024 | ||
| DYNC1H1 | dynein, cytoplasmic 1, heavy chain 1 | 0.024 | ||
| GIPC2 | GIPC PDZ domain containing family, member 2 | 0.024 | ||
| SORBS2 | sorbin and SH3 domain containing 2 | 0.024 | ||
| NOMO1 | NODAL modulator 1 | 0.024 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.024 | ||
| CSRP1 | cysteine and glycine-rich protein 1 | 0.024 | Human | |
| NBR1 | neighbor of BRCA1 gene 1 | 0.024 | ||
| ACTN4 | actinin, alpha 4 | 0.024 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.024 | ||
| PPFIA4 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | 0.023 | ||
| CACNG1 | calcium channel, voltage-dependent, gamma subunit 1 | 0.023 | ||
| PGM5 | phosphoglucomutase 5 | 0.023 | ||
| MYOC | myocilin, trabecular meshwork inducible glucocorticoid response | 0.023 | ||
| VCL | vinculin | 0.023 | ||
| PPP1R3A | protein phosphatase 1, regulatory (inhibitor) subunit 3A | 0.023 | ||
| CAP2 | CAP, adenylate cyclase-associated protein, 2 (yeast) | 0.023 | ||
| MYLK | myosin light chain kinase | 0.023 | ||
| TAGLN2 | transgelin 2 | 0.022 | ||
| DIO2 | deiodinase, iodothyronine, type II | 0.022 | ||
| KBTBD5 | kelch repeat and BTB (POZ) domain containing 5 | 0.022 | ||
| DNAJB4 | DnaJ (Hsp40) homolog, subfamily B, member 4 | 0.022 | ||
| SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 | 0.022 | ||
| FKBP1B | FK506 binding protein 1B, 12.6 kDa | 0.022 | ||
| SGCD | sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) | 0.022 | ||
| PALLD | palladin, cytoskeletal associated protein | 0.022 | Human | |
| RAI14 | retinoic acid induced 14 | 0.022 | ||
| ART3 | ADP-ribosyltransferase 3 | 0.022 | ||
| TP53BP1 | tumor protein p53 binding protein 1 | 0.021 | ||
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 0.021 | ||
| ALOX12 | arachidonate 12-lipoxygenase | 0.021 | ||
| MYLK3 | myosin light chain kinase 3 | 0.021 | ||
| FHOD3 | formin homology 2 domain containing 3 | 0.021 | ||
| PARP3 | poly (ADP-ribose) polymerase family, member 3 | 0.021 | ||
| PDLIM1 | PDZ and LIM domain 1 | 0.021 | Human | |
| ACTB | actin, beta | 0.021 | Human | |
| GADD45A | growth arrest and DNA-damage-inducible, alpha | 0.021 | ||
| MLIP | muscular LMNA-interacting protein | 0.021 | ||
| TMEM47 | transmembrane protein 47 | 0.020 | ||
| KCNJ8 | potassium inwardly-rectifying channel, subfamily J, member 8 | 0.020 | ||
| ANK2 | ankyrin 2, neuronal | 0.020 | ||
| DHRS7C | dehydrogenase/reductase (SDR family) member 7C | 0.020 | ||
| CTNND1 | catenin (cadherin-associated protein), delta 1 | 0.020 | Human | |
| APBA1 | amyloid beta (A4) precursor protein-binding, family A, member 1 | 0.020 | ||
| SRL | sarcalumenin | 0.020 | ||
| DSG1 | desmoglein 1 | 0.020 | Human | |
| C1orf105 | chromosome 1 open reading frame 105 | 0.020 | ||
| KRT36 | keratin 36 | 0.020 | ||
| TUBA1A | tubulin, alpha 1a | 0.019 | ||
| SCN2B | sodium channel, voltage-gated, type II, beta | 0.019 | ||
| HOXA1 | homeobox A1 | 0.019 | ||
| MRAS | muscle RAS oncogene homolog | 0.019 | ||
| MYOF | myoferlin | 0.019 | ||
| S100A10 | S100 calcium binding protein A10 | 0.019 | ||
| FHL5 | four and a half LIM domains 5 | 0.019 | ||
| PLA2G16 | phospholipase A2, group XVI | 0.019 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.019 | ||
| GNG11 | guanine nucleotide binding protein (G protein), gamma 11 | 0.019 | ||
| C20orf166 | chromosome 20 open reading frame 166 | 0.019 | ||
| SMAD9 | SMAD family member 9 | 0.019 | ||
| MICAL2 | microtubule associated monoxygenase, calponin and LIM domain containing 2 | 0.019 | ||
| PHKG1 | phosphorylase kinase, gamma 1 (muscle) | 0.019 | ||
| ITGA7 | integrin, alpha 7 | 0.019 | ||
| MUSTN1 | musculoskeletal, embryonic nuclear protein 1 | 0.019 | ||
| TPD52L1 | tumor protein D52-like 1 | 0.019 | ||
| ZFPM2 | zinc finger protein, multitype 2 | 0.019 | ||
| NPPB | natriuretic peptide B | 0.018 | ||
| CA3 | carbonic anhydrase III, muscle specific | 0.018 | ||
| ASB11 | ankyrin repeat and SOCS box containing 11 | 0.018 | ||
| LMOD3 | leiomodin 3 (fetal) | 0.018 | ||
| GUCA1A | guanylate cyclase activator 1A (retina) | 0.018 | ||
| RRAD | Ras-related associated with diabetes | 0.018 | ||
| GJA5 | gap junction protein, alpha 5, 40kDa | 0.018 | ||
| C10orf71 | chromosome 10 open reading frame 71 | 0.018 | ||
| LMOD1 | leiomodin 1 (smooth muscle) | 0.018 | ||
| PPP1R1A | protein phosphatase 1, regulatory (inhibitor) subunit 1A | 0.018 | ||
| KCNA7 | potassium voltage-gated channel, shaker-related subfamily, member 7 | 0.018 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.018 | ||
| DUSP13 | dual specificity phosphatase 13 | 0.018 | ||
| COX7A1 | cytochrome c oxidase subunit VIIa polypeptide 1 (muscle) | 0.018 | ||
| WDR1 | WD repeat domain 1 | 0.018 | ||
| MAOB | monoamine oxidase B | 0.018 | ||
| PLA2G5 | phospholipase A2, group V | 0.018 | ||
| ANKRD23 | ankyrin repeat domain 23 | 0.018 | ||
| CNN2 | calponin 2 | 0.018 | ||
| MYOM3 | myomesin family, member 3 | 0.018 | ||
| GABARAPL1 | GABA(A) receptor-associated protein like 1 | 0.018 | ||
| ATP1B4 | ATPase, Na+/K+ transporting, beta 4 polypeptide | 0.018 | ||
| COL14A1 | collagen, type XIV, alpha 1 | 0.017 | ||
| EFTUD2 | elongation factor Tu GTP binding domain containing 2 | 0.017 | ||
| MUSK | muscle, skeletal, receptor tyrosine kinase | 0.017 | ||
| TUBB2A | tubulin, beta 2A | 0.017 | ||
| THBS4 | thrombospondin 4 | 0.017 | ||
| TGOLN2 | trans-golgi network protein 2 | 0.017 | ||
| STX16 | syntaxin 16 | 0.017 | ||
| SCN1B | sodium channel, voltage-gated, type I, beta | 0.017 | ||
| HSPA2 | heat shock 70kDa protein 2 | 0.017 | ||
| SESN2 | sestrin 2 | 0.017 | ||
| ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 polypeptide | 0.017 | ||
| UBQLN1 | ubiquilin 1 | 0.017 | ||
| UNC45B | unc-45 homolog B (C. elegans) | 0.017 | ||
| NLRP2 | NLR family, pyrin domain containing 2 | 0.017 | ||
| SPTB | spectrin, beta, erythrocytic | 0.017 | ||
| ACTG2 | actin, gamma 2, smooth muscle, enteric | 0.017 | Human | |
| MPZL2 | myelin protein zero-like 2 | 0.017 | ||
| MYO18B | myosin XVIIIB | 0.017 | ||
| GSN | gelsolin | 0.017 | ||
| EXTL2 | exostoses (multiple)-like 2 | 0.017 | ||
| EEF1G | eukaryotic translation elongation factor 1 gamma | 0.016 | ||
| CLTC | clathrin, heavy chain (Hc) | 0.016 | ||
| DUSP26 | dual specificity phosphatase 26 (putative) | 0.016 | ||
| ZFYVE1 | zinc finger, FYVE domain containing 1 | 0.016 | ||
| FAM189A2 | family with sequence similarity 189, member A2 | 0.016 | ||
| HK2 | hexokinase 2 | 0.016 | ||
| PRMT2 | protein arginine methyltransferase 2 | 0.016 | ||
| HRH2 | histamine receptor H2 | 0.016 | ||
| RASSF9 | Ras association (RalGDS/AF-6) domain family (N-terminal) member 9 | 0.016 | ||
| KCNN1 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 | 0.016 | ||
| UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.016 | ||
| GPC4 | glypican 4 | 0.016 | ||
| PKP1 | plakophilin 1 (ectodermal dysplasia/skin fragility syndrome) | 0.016 | Human | |
| EYA1 | eyes absent homolog 1 (Drosophila) | 0.016 | Human | |
| PRKAG3 | protein kinase, AMP-activated, gamma 3 non-catalytic subunit | 0.016 | Human | |
| MAP2K3 | mitogen-activated protein kinase kinase 3 | 0.016 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.016 | ||
| TRDN | triadin | 0.016 | ||
| MITF | microphthalmia-associated transcription factor | 0.016 | ||
| FNDC5 | fibronectin type III domain containing 5 | 0.016 | ||
| PALMD | palmdelphin | 0.016 | ||
| TBX5 | T-box 5 | 0.016 | ||
| SNTB2 | syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2) | 0.016 | ||
| PRKG1 | protein kinase, cGMP-dependent, type I | 0.015 | ||
| HFE2 | hemochromatosis type 2 (juvenile) | 0.015 | ||
| SCRG1 | stimulator of chondrogenesis 1 | 0.015 | ||
| FAM176A | family with sequence similarity 176, member A | 0.015 | ||
| CORO6 | coronin 6 | 0.015 | ||
| PRKCE | protein kinase C, epsilon | 0.015 | ||
| PEBP1 | phosphatidylethanolamine binding protein 1 | 0.015 | ||
| STK24 | serine/threonine kinase 24 | 0.015 | ||
| ASB10 | ankyrin repeat and SOCS box containing 10 | 0.015 | ||
| DFNA5 | deafness, autosomal dominant 5 | 0.015 | ||
| CXADR | coxsackie virus and adenovirus receptor | 0.015 | ||
| C3orf43 | chromosome 3 open reading frame 43 | 0.015 | ||
| MFAP5 | microfibrillar associated protein 5 | 0.015 | ||
| CACNA2D1 | calcium channel, voltage-dependent, alpha 2/delta subunit 1 | 0.015 | ||
| NOS3 | nitric oxide synthase 3 (endothelial cell) | 0.015 | ||
| CLCN1 | chloride channel 1, skeletal muscle | 0.015 | ||
| SERPINB9 | serpin peptidase inhibitor, clade B (ovalbumin), member 9 | 0.015 | ||
| KRT9 | keratin 9 | 0.015 | ||
| FXYD1 | FXYD domain containing ion transport regulator 1 | 0.015 | ||
| HHATL | hedgehog acyltransferase-like | 0.015 | ||
| MYH7B | myosin, heavy chain 7B, cardiac muscle, beta | 0.015 | Human | |
| SNTA1 | syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component) | 0.015 | ||
| APLNR | apelin receptor | 0.015 | ||
| KCNJ11 | potassium inwardly-rectifying channel, subfamily J, member 11 | 0.015 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.015 | ||
| RBMS3 | RNA binding motif, single stranded interacting protein 3 | 0.015 | ||
| STAC | SH3 and cysteine rich domain | 0.015 | ||
| MYH13 | myosin, heavy chain 13, skeletal muscle | 0.015 | Human | |
| GAS2L1 | growth arrest-specific 2 like 1 | 0.015 | ||
| RHEB | Ras homolog enriched in brain | 0.015 | ||
| FOXO1 | forkhead box O1 | 0.015 | ||
| NEBL | nebulette | 0.015 | ||
| GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 0.015 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.014 | ||
| SCN7A | sodium channel, voltage-gated, type VII, alpha | 0.014 | ||
| SYPL2 | synaptophysin-like 2 | 0.014 | ||
| PTPRS | protein tyrosine phosphatase, receptor type, S | 0.014 | ||
| ENDOD1 | endonuclease domain containing 1 | 0.014 | ||
| EPB41L3 | erythrocyte membrane protein band 4.1-like 3 | 0.014 | ||
| CD151 | CD151 molecule (Raph blood group) | 0.014 | ||
| SMTNL2 | smoothelin-like 2 | 0.014 | ||
| SPEG | SPEG complex locus | 0.014 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.014 | ||
| PRPH2 | peripherin 2 (retinal degeneration, slow) | 0.014 | ||
| MYO1C | myosin IC | 0.014 | ||
| CDH6 | cadherin 6, type 2, K-cadherin (fetal kidney) | 0.014 | ||
| YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.014 | ||
| HBZ | hemoglobin, zeta | 0.014 | ||
| COQ9 | coenzyme Q9 homolog (S. cerevisiae) | 0.014 | ||
| NOS1 | nitric oxide synthase 1 (neuronal) | 0.014 | ||
| PDE1C | phosphodiesterase 1C, calmodulin-dependent 70kDa | 0.014 | ||
| C12orf39 | chromosome 12 open reading frame 39 | 0.014 | ||
| KLF5 | Kruppel-like factor 5 (intestinal) | 0.014 | ||
| ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.014 | Human | |
| APH1B | anterior pharynx defective 1 homolog B (C. elegans) | 0.014 | ||
| CALML6 | calmodulin-like 6 | 0.014 | ||
| ARHGEF6 | Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6 | 0.014 | ||
| FBXL22 | F-box and leucine-rich repeat protein 22 | 0.013 | ||
| PPP1R16A | protein phosphatase 1, regulatory (inhibitor) subunit 16A | 0.013 | ||
| DUSP27 | dual specificity phosphatase 27 (putative) | 0.013 | ||
| ATP5A1 | ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac muscle | 0.013 | ||
| RYR3 | ryanodine receptor 3 | 0.013 | Human | |
| EMD | emerin | 0.013 | ||
| RHOC | ras homolog gene family, member C | 0.013 | ||
| PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | 0.013 | ||
| TEX101 | testis expressed 101 | 0.013 | ||
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.013 | ||
| MMP16 | matrix metallopeptidase 16 (membrane-inserted) | 0.013 | ||
| EXTL1 | exostoses (multiple)-like 1 | 0.013 | ||
| KRT8 | keratin 8 | 0.013 | ||
| IP6K3 | inositol hexakisphosphate kinase 3 | 0.013 | ||
| PCDHA4 | protocadherin alpha 4 | 0.013 | ||
| MURC | muscle-related coiled-coil protein | 0.013 | ||
| GPC1 | glypican 1 | 0.013 | ||
| PHLDA3 | pleckstrin homology-like domain, family A, member 3 | 0.013 | ||
| DRP2 | dystrophin related protein 2 | 0.013 | ||
| RALGPS2 | Ral GEF with PH domain and SH3 binding motif 2 | 0.013 | ||
| NTF4 | neurotrophin 4 | 0.013 | ||
| VGLL2 | vestigial like 2 (Drosophila) | 0.013 | ||
| SCEL | sciellin | 0.013 | ||
| PNMT | phenylethanolamine N-methyltransferase | 0.013 | ||
| SNCAIP | synuclein, alpha interacting protein | 0.013 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.013 | ||
| ITGB5 | integrin, beta 5 | 0.013 | ||
| FGF6 | fibroblast growth factor 6 | 0.013 | ||
| BDNF | brain-derived neurotrophic factor | 0.013 | ||
| S100A6 | S100 calcium binding protein A6 | 0.013 | ||
| HYAL4 | hyaluronoglucosaminidase 4 | 0.013 | ||
| PYGO1 | pygopus homolog 1 (Drosophila) | 0.013 | ||
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.013 | ||
| TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 0.013 | ||
| BCHE | butyrylcholinesterase | 0.013 | ||
| NTF3 | neurotrophin 3 | 0.013 | ||
| DPF3 | D4, zinc and double PHD fingers, family 3 | 0.013 | ||
| EBF2 | early B-cell factor 2 | 0.013 | ||
| CALR3 | calreticulin 3 | 0.013 | ||
| PDZK1 | PDZ domain containing 1 | 0.013 | ||
| KCNMA1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | 0.013 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.013 | ||
| CLIC5 | chloride intracellular channel 5 | 0.012 | ||
| RAP1A | RAP1A, member of RAS oncogene family | 0.012 | ||
| MTA2 | metastasis associated 1 family, member 2 | 0.012 | ||
| TMCO6 | transmembrane and coiled-coil domains 6 | 0.012 | ||
| PGM1 | phosphoglucomutase 1 | 0.012 | ||
| EYA4 | eyes absent homolog 4 (Drosophila) | 0.012 | ||
| POPDC2 | popeye domain containing 2 | 0.012 | ||
| LBH | limb bud and heart development homolog (mouse) | 0.012 | ||
| CSTF2T | cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa, tau variant | 0.012 | ||
| PPYR1 | pancreatic polypeptide receptor 1 | 0.012 | ||
| SCN5A | sodium channel, voltage-gated, type V, alpha subunit | 0.012 | ||
| TMEM159 | transmembrane protein 159 | 0.012 | ||
| EEF1A2 | eukaryotic translation elongation factor 1 alpha 2 | 0.012 | ||
| UCP3 | uncoupling protein 3 (mitochondrial, proton carrier) | 0.012 | ||
| PDE3A | phosphodiesterase 3A, cGMP-inhibited | 0.012 | ||
| ASB15 | ankyrin repeat and SOCS box containing 15 | 0.012 | ||
| GABARAPL2 | GABA(A) receptor-associated protein-like 2 | 0.012 | ||
| FAP | fibroblast activation protein, alpha | 0.012 | ||
| TYRP1 | tyrosinase-related protein 1 | 0.012 | ||
| MED31 | mediator complex subunit 31 | 0.012 | ||
| PMF1 | polyamine-modulated factor 1 | 0.012 | ||
| ASB5 | ankyrin repeat and SOCS box containing 5 | 0.012 | ||
| SLC10A3 | solute carrier family 10 (sodium/bile acid cotransporter family), member 3 | 0.012 | ||
| DSPP | dentin sialophosphoprotein | 0.012 | ||
| GSDMC | gasdermin C | 0.012 | ||
| CD24 | CD24 molecule | 0.012 | ||
| CACNB1 | calcium channel, voltage-dependent, beta 1 subunit | 0.012 | ||
| SEMG2 | semenogelin II | 0.012 | ||
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.012 | ||
| HIGD1B | HIG1 hypoxia inducible domain family, member 1B | 0.012 | ||
| ARHGAP28 | Rho GTPase activating protein 28 | 0.012 | ||
| ITGB6 | integrin, beta 6 | 0.012 | ||
| LGI1 | leucine-rich, glioma inactivated 1 | 0.012 | ||
| RHOJ | ras homolog gene family, member J | 0.012 | ||
| INPP4B | inositol polyphosphate-4-phosphatase, type II, 105kDa | 0.012 | ||
| ASXL2 | additional sex combs like 2 (Drosophila) | 0.012 | ||
| KRT27 | keratin 27 | 0.012 | ||
| SMTN | smoothelin | 0.012 | ||
| KCNN3 | potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3 | 0.012 | ||
| RHOBTB1 | Rho-related BTB domain containing 1 | 0.012 | ||
| SH3BGR | SH3 domain binding glutamic acid-rich protein | 0.012 | ||
| NAP1L5 | nucleosome assembly protein 1-like 5 | 0.012 | ||
| FZD9 | frizzled homolog 9 (Drosophila) | 0.012 | ||
| APOD | apolipoprotein D | 0.012 | ||
| NELL1 | NEL-like 1 (chicken) | 0.012 | ||
| PCBP2 | poly(rC) binding protein 2 | 0.012 | ||
| IL17B | interleukin 17B | 0.012 | ||
| CMYA5 | cardiomyopathy associated 5 | 0.012 | ||
| POPDC3 | popeye domain containing 3 | 0.012 | ||
| ESRRB | estrogen-related receptor beta | 0.012 | ||
| LMO7 | LIM domain 7 | 0.012 | ||
| MSTN | myostatin | 0.012 | ||
| TBX15 | T-box 15 | 0.012 | ||
| ADAM23 | ADAM metallopeptidase domain 23 | 0.012 | ||
| AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.012 | ||
| MTRF1 | mitochondrial translational release factor 1 | 0.012 | ||
| TMBIM1 | transmembrane BAX inhibitor motif containing 1 | 0.012 | ||
| TBX20 | T-box 20 | 0.012 | ||
| C1orf198 | chromosome 1 open reading frame 198 | 0.012 | ||
| LASS1 | LAG1 homolog, ceramide synthase 1 | 0.012 | ||
| SYNC | syncoilin, intermediate filament protein | 0.012 | ||
| MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.012 | ||
| SLCO5A1 | solute carrier organic anion transporter family, member 5A1 | 0.012 | ||
| GSTM4 | glutathione S-transferase mu 4 | 0.012 | ||
| PACRG | PARK2 co-regulated | 0.012 | ||
| DAND5 | DAN domain family, member 5 | 0.011 | ||
| ARL3 | ADP-ribosylation factor-like 3 | 0.011 | ||
| ACO2 | aconitase 2, mitochondrial | 0.011 | ||
| NGF | nerve growth factor (beta polypeptide) | 0.011 | ||
| HIST1H1A | histone cluster 1, H1a | 0.011 | ||
| PTTG1IP | pituitary tumor-transforming 1 interacting protein | 0.011 | ||
| MCCC1 | methylcrotonoyl-CoA carboxylase 1 (alpha) | 0.011 | ||
| BACE1 | beta-site APP-cleaving enzyme 1 | 0.011 | ||
| FST | follistatin | 0.011 | ||
| ECSIT | ECSIT homolog (Drosophila) | 0.011 | ||
| ACADL | acyl-CoA dehydrogenase, long chain | 0.011 | ||
| MYO10 | myosin X | 0.011 | ||
| GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.011 | ||
| COL4A4 | collagen, type IV, alpha 4 | 0.011 | ||
| ZFHX4 | zinc finger homeobox 4 | 0.011 | ||
| CDH13 | cadherin 13, H-cadherin (heart) | 0.011 | Human | |
| FMOD | fibromodulin | 0.011 | ||
| ITIH3 | inter-alpha (globulin) inhibitor H3 | 0.011 | ||
| ATP2B4 | ATPase, Ca++ transporting, plasma membrane 4 | 0.011 | ||
| ABLIM3 | actin binding LIM protein family, member 3 | 0.011 | ||
| HIF3A | hypoxia inducible factor 3, alpha subunit | 0.011 | ||
| LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.011 | ||
| PAWR | PRKC, apoptosis, WT1, regulator | 0.011 | ||
| OGN | osteoglycin | 0.011 | ||
| NPLOC4 | nuclear protein localization 4 homolog (S. cerevisiae) | 0.011 | ||
| NUBPL | nucleotide binding protein-like | 0.011 | ||
| FAM154A | family with sequence similarity 154, member A | 0.011 | ||
| ZNF514 | zinc finger protein 514 | 0.011 | ||
| FYCO1 | FYVE and coiled-coil domain containing 1 | 0.011 | ||
| DOT1L | DOT1-like, histone H3 methyltransferase (S. cerevisiae) | 0.011 | ||
| KLC4 | kinesin light chain 4 | 0.011 | ||
| C5orf55 | chromosome 5 open reading frame 55 | 0.011 | ||
| NRD1 | nardilysin (N-arginine dibasic convertase) | 0.011 | ||
| MLLT3 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 3 | 0.011 | ||
| FRK | fyn-related kinase | 0.011 | ||
| TEAD1 | TEA domain family member 1 (SV40 transcriptional enhancer factor) | 0.011 | ||
| PCDH7 | protocadherin 7 | 0.011 | ||
| CAMK2A | calcium/calmodulin-dependent protein kinase II alpha | 0.011 | ||
| S100A16 | S100 calcium binding protein A16 | 0.011 | ||
| ACHE | acetylcholinesterase | 0.011 | ||
| KRT33A | keratin 33A | 0.011 | ||
| PDE7B | phosphodiesterase 7B | 0.011 | ||
| MALT1 | mucosa associated lymphoid tissue lymphoma translocation gene 1 | 0.011 | ||
| S100A2 | S100 calcium binding protein A2 | 0.011 | ||
| PHEX | phosphate regulating endopeptidase homolog, X-linked | 0.011 | ||
| ZNF132 | zinc finger protein 132 | 0.011 | ||
| RIC8A | resistance to inhibitors of cholinesterase 8 homolog A (C. elegans) | 0.011 | ||
| AFP | alpha-fetoprotein | 0.011 | ||
| EPCAM | epithelial cell adhesion molecule | 0.011 | ||
| OSM | oncostatin M | 0.011 | ||
| FAM110B | family with sequence similarity 110, member B | 0.011 | ||
| TSSK2 | testis-specific serine kinase 2 | 0.011 | ||
| C8orf22 | chromosome 8 open reading frame 22 | 0.011 | ||
| SPATA19 | spermatogenesis associated 19 | 0.011 | ||
| TIAM2 | T-cell lymphoma invasion and metastasis 2 | 0.011 | ||
| CHRNA2 | cholinergic receptor, nicotinic, alpha 2 (neuronal) | 0.011 | ||
| LRRC2 | leucine rich repeat containing 2 | 0.011 | ||
| MT4 | metallothionein 4 | 0.011 | ||
| KCNA4 | potassium voltage-gated channel, shaker-related subfamily, member 4 | 0.011 | ||
| KRT34 | keratin 34 | 0.011 | ||
| HDAC4 | histone deacetylase 4 | 0.011 | ||
| RCAN2 | regulator of calcineurin 2 | 0.011 | ||
| RERGL | RERG/RAS-like | 0.011 | ||
| ZNF71 | zinc finger protein 71 | 0.011 | ||
| AQP7 | aquaporin 7 | 0.011 | ||
| ACAT1 | acetyl-CoA acetyltransferase 1 | 0.011 | ||
| ACO1 | aconitase 1, soluble | 0.011 | ||
| PPP2R3A | protein phosphatase 2, regulatory subunit B'', alpha | 0.011 | ||
| CLCN4 | chloride channel 4 | 0.011 | ||
| CLDN16 | claudin 16 | 0.011 | ||
| C1orf49 | chromosome 1 open reading frame 49 | 0.011 | ||
| MUM1L1 | melanoma associated antigen (mutated) 1-like 1 | 0.011 | ||
| TAF5L | TAF5-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa | 0.011 | ||
| STC2 | stanniocalcin 2 | 0.011 | ||
| FOSL2 | FOS-like antigen 2 | 0.011 | ||
| ZNF471 | zinc finger protein 471 | 0.011 | ||
| MAP4 | microtubule-associated protein 4 | 0.011 | ||
| ANP32D | acidic (leucine-rich) nuclear phosphoprotein 32 family, member D | 0.011 | ||
| SLC8A1 | solute carrier family 8 (sodium/calcium exchanger), member 1 | 0.011 | ||
| CORIN | corin, serine peptidase | 0.011 | ||
| XK | X-linked Kx blood group (McLeod syndrome) | 0.011 | ||
| UBB | ubiquitin B | 0.011 | ||
| PLCB4 | phospholipase C, beta 4 | 0.011 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.010 | ||
| ENG | endoglin | 0.010 | ||
| TSPAN8 | tetraspanin 8 | 0.010 | ||
| CDH10 | cadherin 10, type 2 (T2-cadherin) | 0.010 | ||
| HAND1 | heart and neural crest derivatives expressed 1 | 0.010 | ||
| ZNF155 | zinc finger protein 155 | 0.010 | ||
| FMNL2 | formin-like 2 | 0.010 | ||
| PSENEN | presenilin enhancer 2 homolog (C. elegans) | 0.010 | ||
| BMP4 | bone morphogenetic protein 4 | 0.010 | ||
| KCNB1 | potassium voltage-gated channel, Shab-related subfamily, member 1 | 0.010 | ||
| CDH2 | cadherin 2, type 1, N-cadherin (neuronal) | 0.010 | Human | |
| BCAR3 | breast cancer anti-estrogen resistance 3 | 0.010 | ||
| RCAN3 | RCAN family member 3 | 0.010 | ||
| TCF15 | transcription factor 15 (basic helix-loop-helix) | 0.010 | ||
| CLIP4 | CAP-GLY domain containing linker protein family, member 4 | 0.010 | ||
| SGCB | sarcoglycan, beta (43kDa dystrophin-associated glycoprotein) | 0.010 | Human | |
| TSPAN2 | tetraspanin 2 | 0.010 | ||
| SPINT2 | serine peptidase inhibitor, Kunitz type, 2 | 0.010 | ||
| PDE11A | phosphodiesterase 11A | 0.010 | ||
| MFGE8 | milk fat globule-EGF factor 8 protein | 0.010 | ||
| SIM1 | single-minded homolog 1 (Drosophila) | 0.010 | ||
| SYVN1 | synovial apoptosis inhibitor 1, synoviolin | 0.010 | ||
| AKAP12 | A kinase (PRKA) anchor protein 12 | 0.010 | ||
| HTR7 | 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) | 0.010 | ||
| RXRG | retinoid X receptor, gamma | 0.010 | ||
| SLC20A2 | solute carrier family 20 (phosphate transporter), member 2 | 0.010 | ||
| KIF25 | kinesin family member 25 | 0.010 | ||
| DNAJA4 | DnaJ (Hsp40) homolog, subfamily A, member 4 | 0.010 | ||
| RAB30 | RAB30, member RAS oncogene family | 0.010 | ||
| ANKRD57 | ankyrin repeat domain 57 | 0.010 | ||
| ANGPT2 | angiopoietin 2 | 0.010 | ||
| ITLN1 | intelectin 1 (galactofuranose binding) | 0.010 | ||
| SPACA3 | sperm acrosome associated 3 | 0.010 | ||
| HAND2 | heart and neural crest derivatives expressed 2 | 0.010 | ||
| AQP4 | aquaporin 4 | 0.010 | ||
| LDHC | lactate dehydrogenase C | 0.010 | ||
| EIF1 | eukaryotic translation initiation factor 1 | 0.010 | ||
| POSTN | periostin, osteoblast specific factor | 0.010 | ||
| SREBF1 | sterol regulatory element binding transcription factor 1 | 0.010 | ||
| TPM3 | tropomyosin 3 | 0.010 | Human | |
| ADAMTS12 | ADAM metallopeptidase with thrombospondin type 1 motif, 12 | 0.010 | ||
| PARD3 | par-3 partitioning defective 3 homolog (C. elegans) | 0.010 | ||
| C13orf1 | chromosome 13 open reading frame 1 | 0.010 | ||
| TAC3 | tachykinin 3 | 0.010 | ||
| PLCL1 | phospholipase C-like 1 | 0.010 | ||
| TMEM168 | transmembrane protein 168 | 0.010 | ||
| RBM41 | RNA binding motif protein 41 | 0.010 | ||
| NAV3 | neuron navigator 3 | 0.010 | ||
| CROT | carnitine O-octanoyltransferase | 0.010 | ||
| RGS5 | regulator of G-protein signaling 5 | 0.010 | ||
| CLTCL1 | clathrin, heavy chain-like 1 | 0.010 | ||
| FILIP1L | filamin A interacting protein 1-like | 0.010 | ||
| DYSFIP1 | dysferlin interacting protein 1 | 0.010 | ||
| DDIT4L | DNA-damage-inducible transcript 4-like | 0.010 | ||
| HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.010 | ||
| E2F2 | E2F transcription factor 2 | 0.010 | ||
| RAC3 | ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3) | 0.010 | ||
| CTSL2 | cathepsin L2 | 0.010 | ||
| FILIP1 | filamin A interacting protein 1 | 0.010 | ||
| MAB21L1 | mab-21-like 1 (C. elegans) | 0.010 | ||
| SEMA3A | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3A | 0.010 | ||
| ASPA | aspartoacylase | 0.010 | ||
| C9orf3 | chromosome 9 open reading frame 3 | 0.010 | ||
| SH3D19 | SH3 domain containing 19 | 0.010 | ||
| GSTT1 | glutathione S-transferase theta 1 | 0.010 | ||
| USP2 | ubiquitin specific peptidase 2 | 0.010 | ||
| ITGA8 | integrin, alpha 8 | 0.010 | ||
| C7orf10 | chromosome 7 open reading frame 10 | 0.010 | ||
| RPH3AL | rabphilin 3A-like (without C2 domains) | 0.010 | ||
| ST8SIA5 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5 | 0.010 | ||
| EPM2A | epilepsy, progressive myoclonus type 2A, Lafora disease (laforin) | 0.010 | ||
| NEXN | nexilin (F actin binding protein) | 0.010 | ||
| ING1 | inhibitor of growth family, member 1 | 0.010 | ||
| SLC16A10 | solute carrier family 16, member 10 (aromatic amino acid transporter) | 0.010 | ||
| DMD | dystrophin | 0.010 | ||
| CTNNA3 | catenin (cadherin-associated protein), alpha 3 | 0.009 | ||
| PRKAG2 | protein kinase, AMP-activated, gamma 2 non-catalytic subunit | 0.009 | ||
| RYR2 | ryanodine receptor 2 (cardiac) | 0.007 | ||
| GATAD1 | GATA zinc finger domain containing 1 | 0.007 | ||
| RBM20 | RNA binding motif protein 20 | 0.006 | ||
| TMEM43 | transmembrane protein 43 | 0.006 | ||
| LAMA4 | laminin, alpha 4 | 0.005 | ||
| FKTN | fukutin | 0.004 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.003 | ||
| LMNA | lamin A/C | 0.003 | ||
| SDHA | succinate dehydrogenase complex, subunit A, flavoprotein (Fp) | 0.003 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.002 |